Newsbenzinga
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths
· Published
Article summary
Novartis and Bristol Myers pause CAR-T autoimmune trials after patient deaths and severe side effects spark safety concerns.
An excerpt from the original article.
Comments —
Loading comments…